Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 15 OTHER 13 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 48 Magnetic Resonance Spectroscopy 39 Cyclophosphamide 29 Vincristine 23 Radiation 20 Dexamethasone 19 Radiotherapy 18 Etoposide 18 Cisplatin 18 Biopsy 18 Carboplatin 17 Doxorubicin 13 Cytarabine 13 daratumumab 12 Leucovorin 12 Methotrexate 11 Gemcitabine 11 X-Rays 10 Standard of Care 10 Radiotherapy, Intensity-Modulated 10 Platinum 10 Docetaxel 10 durvalumab 9 Rituximab 9 Radiotherapy, Conformal 9 Prednisone 9 Practice Guidelines as Topic 9 Calcium Dobesilate 9 1,2-diaminocyclohexaneplatinum II citrate 9 merphos 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × trifluridine tipiracil drug combination × 90 days × Clear all

NCT04489173 2026-05-22

TIBET

Borstkanker Onderzoek Groep

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡